Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.

MLA

Nørgaard, Mette, et al. “Risk of Arterial Thrombotic and Venous Thromboembolic Events in Patients with Primary Chronic Immune Thrombocytopenia: A Scandinavian Population-Based Cohort Study.” British Journal of Haematology, vol. 174, no. 4, Aug. 2016, pp. 639–42. EBSCOhost, https://doi.org/10.1111/bjh.13787.

APA

Nørgaard, M., Cetin, K., Mægbæk, M. L., Kristensen, N. R., Ghanima, W., Bahmanyar, S., Stryker, S., & Christiansen, C. F. (2016). Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study. British Journal of Haematology, 174(4), 639–642. https://doi.org/10.1111/bjh.13787

Chicago

Nørgaard, Mette, Karynsa Cetin, Merete Lund Mægbæk, Nickolaj Risbo Kristensen, Waleed Ghanima, Shahram Bahmanyar, Scott Stryker, and Christian Fynbo Christiansen. 2016. “Risk of Arterial Thrombotic and Venous Thromboembolic Events in Patients with Primary Chronic Immune Thrombocytopenia: A Scandinavian Population-Based Cohort Study.” British Journal of Haematology 174 (4): 639–42. doi:10.1111/bjh.13787.